Temporal Trends in Survival and Healthcare Costs in Patients with Multiple Myeloma in the United States

In recent years, the development of new therapies for multiple myeloma has improved the survival of patients, but newer treatments may also affect healthcare costs. To date, no real-world study has examined the concurrent changes in survival and total healthcare costs over time in patients with multiple myeloma